Rabies Vaccine (Human diploid cell), Chengdu Kanghua Biological

冻干人用狂犬病疫苗（人二倍体细胞）

Report date: 2026/05/26 20:00:28

Base Information

Drug NameRabies Vaccine (Human diploid cell), Chengdu Kanghua Biological
Drug Alias NameHDCVHDCV rabies vaccine-Chengdu Kanghua Biological ProductsMRC-5 cell rabies vaccine-Chengdu Kanghua Biological ProductsFreeze dried rabies vaccine-Chengdu Kanghua Biological ProductsHuman diploid cell rabies vaccine-Chengdu Kanghua Biological Products +[7] 
ClassificationVaccines > Application > Prophylactic vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II)
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRabies
Global Approved IndicationsRabies
Approved Indications in ChinaRabies
Original Approved Country/TerritoryMainland China
Original Approved Date2012/04/28
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesChengdu Kanghua Biological Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChengdu Kanghua Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsRabies
Inactive IndicationsN/A

Other Information

ATC CodeJ07BG01
Related LinksN/A